212 related articles for article (PubMed ID: 15674481)
1. Apoptosis in gliomas: molecular mechanisms and therapeutic implications.
Steinbach JP; Weller M
J Neurooncol; 2004 Nov; 70(2):245-54. PubMed ID: 15674481
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis in Gliomas: Molecular Mechanisms and Therapeutic Implications.
Steinbach JP; Weller M
J Neurooncol; 2004 Nov; 70(2):247-256. PubMed ID: 15674482
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B
Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human glioma cell proliferation by altered Bax/Bcl-2-p53 expression and apoptosis induction by Rhaponticum carthamoides extracts from transformed and normal roots.
Skała E; Sitarek P; Toma M; Szemraj J; Radek M; Nieborowska-Skorska M; Skorski T; Wysokińska H; Śliwiński T
J Pharm Pharmacol; 2016 Nov; 68(11):1454-1464. PubMed ID: 27696406
[TBL] [Abstract][Full Text] [Related]
5. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
[TBL] [Abstract][Full Text] [Related]
6. p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal.
Batista LF; Roos WP; Kaina B; Menck CF
Mol Cancer Res; 2009 Feb; 7(2):237-46. PubMed ID: 19208740
[TBL] [Abstract][Full Text] [Related]
7. Microtubule inhibitor D-24851 induces p53-independent apoptotic cell death in malignant glioma cells through Bcl-2 phosphorylation and Bax translocation.
Ito H; Kanzawa T; Kondo S; Kondo Y
Int J Oncol; 2005 Mar; 26(3):589-96. PubMed ID: 15703812
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
9. Trans-4-lodo,4'-boranyl-chalcone induces antitumor activity against malignant glioma cell lines in vitro and in vivo.
Sasayama T; Tanaka K; Mizukawa K; Kawamura A; Kondoh T; Hosoda K; Kohmura E
J Neurooncol; 2007 Nov; 85(2):123-32. PubMed ID: 17530176
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.
Zupanska A; Dziembowska M; Ellert-Miklaszewska A; Gaweda-Walerych K; Kaminska B
Neurochem Int; 2005 Nov; 47(6):430-41. PubMed ID: 16087277
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
Tianqin G; Chunlei C; Jingjing W
Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785
[TBL] [Abstract][Full Text] [Related]
12. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
Glaser T; Winter S; Groscurth P; Safayhi H; Sailer ER; Ammon HP; Schabet M; Weller M
Br J Cancer; 1999 May; 80(5-6):756-65. PubMed ID: 10360653
[TBL] [Abstract][Full Text] [Related]
13. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
Fulda S; Wick W; Weller M; Debatin KM
Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
[TBL] [Abstract][Full Text] [Related]
14. BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.
Rieger L; Weller M; Bornemann A; Schabet M; Dichgans J; Meyermann R
J Neurol Sci; 1998 Feb; 155(1):68-75. PubMed ID: 9562325
[TBL] [Abstract][Full Text] [Related]
15. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
16. Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.
Weller M; Rieger J; Grimmel C; Van Meir EG; De Tribolet N; Krajewski S; Reed JC; von Deimling A; Dichgans J
Int J Cancer; 1998 Dec; 79(6):640-4. PubMed ID: 9842975
[TBL] [Abstract][Full Text] [Related]
17. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
18. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
Glaser T; Wagenknecht B; Groscurth P; Krammer PH; Weller M
Oncogene; 1999 Sep; 18(36):5044-53. PubMed ID: 10490841
[TBL] [Abstract][Full Text] [Related]
19. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.
Weller M; Trepel M; Grimmel C; Schabet M; Bremen D; Krajewski S; Reed JC
Neurol Res; 1997 Oct; 19(5):459-70. PubMed ID: 9329022
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells.
Kondo S; Barna BP; Morimura T; Takeuchi J; Yuan J; Akbasak A; Barnett GH
Cancer Res; 1995 Dec; 55(24):6166-71. PubMed ID: 8521409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
